Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Exosomes as novel biomarkers in metabolic disease and obesity-related cancers

Nature Reviews Endocrinology volume 18, pages 327–328 (2022)Cite this article

Subjects

Exosomes include plasma-transported vesicles that are secreted by human tissues and reflect metabolic status. The profile of exosomes (particularly microRNA content) is altered in metabolic disease. In type 2 diabetes mellitus, exosomes circulating in plasma induce transcriptional changes related to tumour progression and pro-metastatic phenotypes in target cancer cells, potentially linking obesity to cancer progression and metastasis.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Circulating exosomes in metabolic disorders could induce tumour progression.

References

  1. Trams, E. G., Lauter, C. J., Salem, N. Jr & Heine, U. Exfoliation of membrane ecto-enzymes in the form of micro-vesicles. Biochim. Biophys. Acta 645, 63–70 (1981).

    Article  CAS  Google Scholar 

  2. Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654–659 (2007).

    Article  CAS  Google Scholar 

  3. Guescini, M., Genedani, S., Stocchi, V. & Agnati, L. F. Astrocytes and glioblastoma cells release exosomes carrying mtDNA. J. Neural Transm. 117, 1–4 (2010).

    Article  CAS  Google Scholar 

  4. Jafari, N. et al. Novel plasma exosome biomarkers for prostate cancer progression in co-morbid metabolic disease. Preprint at bioRxiv https://doi.org/10.1101/2022.02.01.478722 (2022).

    Article  Google Scholar 

  5. Jafari, N. et al. Adipocyte-derived exosomes may promote breast cancer progression in type 2 diabetes. Sci. Signal. 14, eabj2807 (2021).

    Article  CAS  Google Scholar 

  6. Freeman, D. W. et al. Altered extracellular vesicle concentration, cargo, and function in diabetes. Diabetes 67, 2377–2388 (2018).

    Article  CAS  Google Scholar 

  7. Overbeek, J. A. et al. Type 2 diabetes, but not insulin (analog) treatment, is associated with more advanced stages of breast cancer: a national linkage of cancer and pharmacy registries. Diabetes Care 42, 434–442 (2019).

    Article  CAS  Google Scholar 

  8. Elfeky, O., Longo, S., Lai, A., Rice, G. E. & Salomon, C. Influence of maternal BMI on the exosomal profile during gestation and their role on maternal systemic inflammation. Placenta 50, 60–69 (2017).

    Article  Google Scholar 

  9. Yang, X. & Wu, N. MicroRNAs and exosomal microRNAs may be possible targets to investigate in gestational diabetes mellitus. Diabetes Metab. Syndr. Obes. 15, 321–330 (2022).

    Article  Google Scholar 

  10. Perrin, M. C. et al. Gestational diabetes as a risk factor for pancreatic cancer: a prospective cohort study. BMC Med. 5, 25 (2007).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Boston University–Boston Medical Center Cancer Center, Boston University School of Medicine, Boston, MA, USA

    Naser Jafari, Pablo Llevenes & Gerald V. Denis

  2. Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA

    Pablo Llevenes & Gerald V. Denis

  3. Section of Hematology and Medical Oncology, Department of Medicine, Boston University Medical Center, Boston, MA, USA

    Gerald V. Denis

Authors
  1. Naser Jafari
    View author publications

    Search author on:PubMed Google Scholar

  2. Pablo Llevenes
    View author publications

    Search author on:PubMed Google Scholar

  3. Gerald V. Denis
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Gerald V. Denis.

Ethics declarations

Competing interests

G.V.D. and N.J. are inventors on US patent 63/171,689 to use exosomes as a cancer diagnostic. P.L. declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jafari, N., Llevenes, P. & Denis, G.V. Exosomes as novel biomarkers in metabolic disease and obesity-related cancers. Nat Rev Endocrinol 18, 327–328 (2022). https://doi.org/10.1038/s41574-022-00666-7

Download citation

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41574-022-00666-7

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer